Blake Farrow

Blake Farrow

Auto-generated profile, based on publicly available information

Blake Farrow

Dep. of Plant and Soil Sciences; 371 Agricultural Hall; Oklahoma State Univ.; Stillwater OK 74078-6027

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2011 in The Journal of Physical Chemistry C
Verified
Journal Article
Closed access
ADAaron Davies
Aaron Davies
PAPhilippe Audette
Philippe Audette
BFBlake Farrow
Blake Farrow
FHFathy Hassan
Fathy Hassan
ZCZhongwei Chen
Zhongwei Chen
AYAiping Yu
Aiping Yu

15 July 2009 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
BFBlake Farrow
Blake Farrow
PKPrashant V. Kamat
Prashant V. Kamat

24 September 2013 in ACS Nano
Verified
Journal Article
Closed access
BFBlake Farrow
Blake Farrow
SHSung A Hong
Sung A Hong
ERErrika C. Romero
Errika C. Romero
BLBert Lai
Bert Lai
MCMatthew B. Coppock
Matthew B. Coppock
JHJames R. Heath
James R. Heath

13 April 2015 in Nature Chemistry
Verified
Journal Article
Open access
PDF file
KDKaycie M. Deyle
Kaycie M. Deyle
BFBlake Farrow
Blake Farrow
YHYing Qiao Hee
Ying Qiao Hee
JWJeremy Work
Jeremy Work
MWMichelle Wong
Michelle Wong
JHJames R. Heath
James R. Heath
Ligands that can bind selectively to proteins with single amino-acid point mutations offer the potential to detect or treat an abnormal protein in the presence of the wild type (WT). However, it is difficult to develop a selective ligand if the point mutation is not associated with an addressable location, such as a binding pocket. Here we report an all-chemical synthetic epitope-targeting strategy that we used to discover a 5-mer peptide with selectivity for the E17K-transforming point mutation in the pleckstrin homology domain of the Akt1 oncoprotein. A fragment of Akt1 that contained the E17K mutation and an I19[propargylglycine] substitution was synthesized to form an addressable synthetic epitope. Azide-presenting peptides that clicked covalently onto this alkyne-presenting epitope were selected from a library using in situ screening. One peptide exhibits a 10:1 in vitro selectivity for the oncoprotein relative to the WT, with a similar selectivity in cells. This 5-mer peptide was expanded into a larger ligand that selectively blocks the E17K Akt1 interaction with its PIP3 (phosphatidylinositol (3,4,5)-trisphosphate) substrate.

7 October 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JPJessica A. Pfeilsticker
Jessica A. Pfeilsticker
AUAiko Umeda
Aiko Umeda
BFBlake Farrow
Blake Farrow
CHConnie L. Hsueh
Connie L. Hsueh
KDKaycie M. Deyle
Kaycie M. Deyle
JHJames R. Heath
James R. Heath
We report on a method to improve in vitro diagnostic assays that detect immune response, with specific application to HIV-1. The inherent polyclonal diversity of the humoral immune response was addressed by using sequential in situ click chemistry to develop a cocktail of peptide-based capture agents, the components of which were raised against different, representative anti-HIV antibodies that bind to a conserved epitope of the HIV-1 envelope protein gp41. The cocktail was used to detect anti-HIV-1 antibodies from a panel of sera collected from HIV-positive patients, with improved signal-to-noise ratio relative to the gold standard commercial recombinant protein antigen. The capture agents were stable when stored as a powder for two months at temperatures close to 60oC.

22 May 2014
Verified
Conference Paper
Closed access
PDF file
MCMatthew B. Coppock
Matthew B. Coppock
BFBlake Farrow
Blake Farrow
CWCandice Warner
Candice Warner
AFAmethist S. Finch
Amethist S. Finch
BLBert Lai
Bert Lai
DSDimitra Stratis-Cullum
Dimitra Stratis-Cullum